Newsroom

News

September 9, 2026

Exclusive: Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinic

Endpoints News

Read article

News

September 9, 2026

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

Business Wire

Read article

Presentations

July 20, 2026

TwoStep Therapeutics to Present at the Targeted Radiopharmaceuticals Summit 2026

Targeted Radiopharmaceuticals Summit 2026

Read article

Presentations

May 28, 2026

TwoStep Therapeutics to Present at Antibody Engineering & Therapeutics Europe 2026

AET Europe 2026

Read article

Presentations

March 11, 2026

TwoStep Therapeutics to Present at the Novel Conjugates Summit 2026

Novel Conjugates Summit 2026

Read article

Presentations

December 17, 2025

TwoStep Therapeutics to Present at Antibody Engineering & Therapeutics US 2025

AET US 2025

Read article

Presentations

November 7, 2025

TwoStep Therapeutics to Present at the 2025 SITC Annual Meeting

SITC 2025

Read article

Presentations

May 13, 2025

TwoStep Therapeutics to Present at the PEGS Boston Summit

PEGS Summit 2025

Read article

News

March 25, 2025

TwoStep Therapeutics Selected to Join Johnson & Johnson’s Global Incubator Network “JLABS”

Business Wire

Read article